Skip to main content

Poor muscle quality: a hidden health condition in obesity

Poor muscle quality is commonly underdiagnosed in people with obesity. Explore the definitions, assessment methods, associated health outcomes, and potential interventions.

Read more

Editor's Choice

Targeting ultra-processed foods for prevention of type 2 diabetes

The increasing availability and intake of UPFs is occurring alongside the rising incidence of obesity and type 2 diabetes. Examine the evidence linking UPFs with excess type 2 diabetes risk.

Detection bias may explain short-term thyroid cancer risk with GLP-1 receptor agonist use

People with type 2 diabetes beginning GLP-1 receptor agonist therapy have a short-term increased risk of thyroid cancer compared with those who initiate alternative diabetes medications.

Immune checkpoint inhibitor-related diabetes

ICI-related diabetes developed after 18 months of nivolumab treatment for malignant melanoma. Diffusion-weighted imaging may provide valuable insights into pancreatic involvement at an early stage of the disease.

SGLT2 inhibitor triggers metabolic encephalopathy

Testing ketone levels and brain MRI is essential for unconscious patients on SGLT2 inhibitors. Patients on these drugs are at increased risk of euglycemic diabetic ketoacidosis, which may cause metabolic encephalopathy.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Prof. Samuel Seidu
Developed by: Adis
Listen now

Case Studies

Immune checkpoint inhibitor-related diabetes

ICI-related diabetes developed after 18 months of nivolumab treatment for malignant melanoma. Diffusion-weighted imaging may provide valuable insights into pancreatic involvement at an early stage of the disease.

SGLT2 inhibitor triggers metabolic encephalopathy

Testing ketone levels and brain MRI is essential for unconscious patients on SGLT2 inhibitors. Patients on these drugs are at increased risk of euglycemic diabetic ketoacidosis, which may cause metabolic encephalopathy.

LADA and Graves disease preceded by minimal change nephrotic syndrome in childhood

A young woman diagnosed with minimal change nephrotic syndrome in childhood developed latent autoimmune diabetes in adults and Graves disease. HLA testing was performed to investigate her genetic background.

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu
Listen now

Current Reviews

Can Spinal Cord Stimulation be Considered as a Frontier for Chronic Pain in Diabetic Foot?

Chronic pain in the diabetic foot (DF) is a common complication of diabetes, bringing a significant burden to patients, their families, and even society. There is no very effective treatment for it, traditional treatments such as medication …

Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

Within the spectrum of cardiovascular diseases, the main cause of morbidity and mortality worldwide, heart failure (HF) is considered one of the most common [ 1 ]. HF is a complex clinical syndrome with symptoms and signs that result from any …

The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis

Metabolic and bariatric surgery (MBS) is a successful surgical option for obesity. However, many patients can experience insufficient weight loss and weight regain post-operatively. Glucagon-like peptide-1 (GLP-1) receptor agonists have become …

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.

Developed by: Springer Medicine
Read more

CME & eLearning

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Tweetorials | Vodcasts | Infographics (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

Further Reading

Role of shearing wave elastography in detecting early diabetic nephropathy

Diabetic nephropathy (DN) is one of the common serious microvascular complications of diabetes mellitus (DM). Diabetic nephropathy occurs in about 20 to 40% of all diabetics who eventually develop end-stage kidney disease [ 1 ]. So, the diagnosis …

Can Spinal Cord Stimulation be Considered as a Frontier for Chronic Pain in Diabetic Foot?

Chronic pain in the diabetic foot (DF) is a common complication of diabetes, bringing a significant burden to patients, their families, and even society. There is no very effective treatment for it, traditional treatments such as medication …

Fertility in male patients with familial Mediterranean fever and paternal effect of FMF on pregnancy outcomes and complications

Familial Mediterranean Fever (FMF) is an autoinflammatory disease characterized by recurrent attacks of fever and polyserositis. These attacks are generally self-limited, typically lasting 1–7 days. Amyloidosis is the most feared complication of …

HYA ameliorated postprandial hyperglycemia in type 1 diabetes model rats with bolus insulin treatment

Fatty acids are a source of energy that are absorbed in the small intestine after digestion of pancreatic lipase. Some fatty acids are sensed by G protein-coupled receptors in the intestinal mucosa [ 1 ], and long-chain fatty acids are agonists of …

Related topics

Managing neuroendocrine tumors and diabetes

  • Free for a limited time
  • Diabetes
  • Review

Diabetes and NET can adversely affect each other’s prognosis, but what impact do NET therapies have on diabetes and vice versa? And how should radiological and functional procedures be managed in patients with NET and diabetes?

Read more